Literature DB >> 4063416

Cholinergic processes in blood samples from patients with major psychiatric disorders.

R S Jope, W G Walter-Ryan, R D Alarcon, K M Lally.   

Abstract

Cholinergic processes were measured in plasma and red blood cells (RBC) obtained from patients with mania, depression, and schizophrenia. RBC choline levels were elevated in manic patients, and lithium treatment led to a further increase. RBC choline transport was below normal in manic patients, and lithium treatment further reduced choline transport in addition to reducing the apparent affinity for choline. RBC acetylcholinesterase was low in depressed and schizophrenic patients, but not in manic patients, whereas plasma acetylcholinesterase was reduced only in depressed patients. Plasma nonspecific cholinesterase was below normal in all groups of patients. These results indicate unique patterns of differences from controls in the cholinergic system in blood samples from patients with different psychiatric illnesses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063416     DOI: 10.1016/0006-3223(85)90110-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  7 in total

Review 1.  Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Gohar Mushtaq; Nigel H Greig; Jalaluddin A Khan; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

2.  N-methyl N-nitrosourea induced functional and structural alterations in mice brain-role of curcumin.

Authors:  Neha Singla; Devinder Kumar Dhawan
Journal:  Neurotox Res       Date:  2012-01-14       Impact factor: 3.911

3.  Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients.

Authors:  Aleksandar R Zivkovic; Karsten Schmidt; Annette Sigl; Sebastian O Decker; Thorsten Brenner; Stefan Hofer
Journal:  Mediators Inflamm       Date:  2015-02-11       Impact factor: 4.711

4.  Amaryllidaceae, Lycopodiaceae Alkaloids and Coumarins-A Comparative Assessment of Safety and Pharmacological Activity.

Authors:  Mariola Herbet; Jarosław Widelski; Iwona Piątkowska-Chmiel; Kamil Pawłowski; Aleksandra Dymek; Tomasz Mroczek
Journal:  J Clin Med       Date:  2022-07-23       Impact factor: 4.964

5.  Increased Levels of Acetylcholinesterase, Paraoxonase 1, and Copper in Patients with Moderate Depression- a Preliminary Study.

Authors:  Shobha Ullas Kamath; Abhishek Chaturvedi; Devesh Bhaskar Yerrapragada; Nagendra Kundapura; Navaneeth Amin; Virupaksha Devaramane
Journal:  Rep Biochem Mol Biol       Date:  2019-01

6.  Effectiveness of zinc in modulating lithium induced biochemical and behavioral changes in rat brain.

Authors:  Punita Bhalla; Vijayta Dani Chadha; D K Dhawan
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 4.231

7.  Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease.

Authors:  Gustavo Alves Andrade Dos Santos; Paulo Renato Canineu; Ivair Donizette Gonçalves; Paulo Celso Pardi
Journal:  Dement Neuropsychol       Date:  2011 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.